MedPath

Metformin for the Treatment of Diabetes in Pregnancy

Phase 3
Conditions
Gestational Diabetes
Diabetes Mellitus Type 2
Registration Number
NCT00414245
Lead Sponsor
Soroka University Medical Center
Brief Summary

The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • pregnant women
  • GDM A2
  • diabetes mellitus type 2
  • singleton pregnancy
Exclusion Criteria
  • diabetic nephropathy or proliferative retinopathy
  • cannot swallow tablets

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
pregnancy complications
glycemic control
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Division of Obstetrics and Gynecology, Soroka University Medical Center

🇮🇱

Beer-Sheva, Israel

© Copyright 2025. All Rights Reserved by MedPath